• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Robert King

    Robert King

    The study looked at whether omega-3 fatty acids, derived mainly from fish oil, can slow cognitive decline in seniors. (iStock photo)
    Healthcare

    Study doubts benefits of fish oil on brain health

    Robert King -
    August 25, 2015 4:20 pm
    0
    In July, the FDA announced it intends to require four types of quality metrics from pharmaceutical manufacturers and three optional ones. It held a meeting to get industry feedback on the metrics on Monday. (AP Photo/Gregory Bull)
    Healthcare

    Government wants to grade drugmakers, but keep grades secret

    Robert King -
    August 25, 2015 4:01 am
    0
    The lawsuit has provided House Republicans with another platform to highlight things they hate about the healthcare law and how the administration has put it in motion. (Getty Images)
    Healthcare

    Obamacare’s latest problem: Narrow doctor networks

    Robert King -
    August 24, 2015 5:02 pm
    0
    In this Friday, Sept. 27, 2013, photo, Cindy Whitehead holds a tablet of flibanserin in her office at Sprout Pharmaceuticals in Raleigh, N.C. The daily pill is designed to increase libido in women by acting on brain chemicals linked to mood and appetite. (AP Photo/Allen G. Breed)
    Healthcare

    OK for female sex drug follows patient-centered trend

    Robert King -
    August 23, 2015 4:01 am
    0
    In 2009, the manufacturer of Zicam voluntarily recalled nasal products using zinc in the drug after consumers claimed they lost their ability to smell. (Getty)
    Healthcare

    Overhaul of rules for homeopathic drugs wanted

    Robert King -
    August 21, 2015 8:44 pm
    0
    Contact lens wearers must wash hands before touching lenses and take out contacts before showering, sleeping or swimming. (Wikimedia Commons)
    Healthcare

    Nearly all contact lens wearers perform risky behaviors: CDC

    Robert King -
    August 20, 2015 5:00 pm
    0
    Rep. Elijah E. Cummings, D-Md., asked the anti-abortion group Center for Medical Progress in a letter Thursday whether it used donations in its undercover investigation of Planned Parenthood. (Getty Images)
    Healthcare

    Democrat demands answers from group behind Planned Parenthood videos

    Robert King -
    August 20, 2015 2:59 pm
    0
    A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals. Valeant Pharmaceuticals will acquire Sprout Pharmaceuticals for about $1 billion. (AP Photo/Allen G. Breed)
    Healthcare

    Female libido drug maker to be sold

    Robert King -
    August 20, 2015 12:14 pm
    0
    Grumblings from insurers indicate that part of the healthcare law is collapsing. (AP Photo/David Mercer)
    Healthcare

    Study: Millions not getting Obamacare subsidies

    Robert King -
    August 19, 2015 3:51 pm
    0
    Sprout Pharmaceuticals CEO Cindy Whitehead holds a bottle for the female sex-drive drug Addyi. After two rejections, the U.S. Food and Drug Administration gave approval Tuesday for the drug as a treatment for hypoactive sexual desire disorder, a first for women. (AP Photo/Allen G. Breed)
    Healthcare

    Female libido drug won’t be marketed on TV

    Robert King -
    August 19, 2015 3:11 pm
    0
    1...318319320...357Page 319 of 357
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.